Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of AngioDynamics Inc (NASDAQ: ANGO) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of AngioDynamics Inc (NASDAQ: ANGO) concerning whether a series of statements by AngioDynamics Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On July 17, 2017, the Company revealed that its auditor discovered that a material weakness existed in its internal control over financial reporting as of May 31, 2016 because AngioDynamics did not design and maintain effective internal controls over the accounting for the annual goodwill impairment test. AngioDynamics lacked effective controls to review in sufficient detail the cash flow projections and significant valuation model assumptions used in the goodwill impairment test as of December 31, 2015.

On this news, NASDAQ: ANGO fell, causing investors harm.

Based in Latham, New York, and founded in 1988 AngioDynamics Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology worldwide.

If you purchased shares of AngioDynamics Inc (NASDAQ: ANGO) on or before July 17, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185